| 封伟亮,谢尚闹,杨红健.原发性乳腺恶性淋巴瘤28例[J].中国肿瘤,2012,21(9):699-702. |
| 原发性乳腺恶性淋巴瘤28例 |
| Primary Breast Lymphoma: a Clinical Analysis of 28 Cases |
| 投稿时间：2012-04-11 |
| DOI： |
|
 |
| 中文关键词: 恶性淋巴瘤 乳腺肿瘤 预后 |
| 英文关键词:malignant lymphoma breast neoplasm prognosis |
| 基金项目: |
|
| 摘要点击次数: 1870 |
| 全文下载次数: 848 |
| 中文摘要: |
| 摘 要: ［目的］ 探讨原发性乳腺恶性淋巴瘤（PBL）的临床病理特点、诊治方法。［方法］ 回顾性分析28例原发性乳腺恶性淋巴瘤临床资料，中位年龄46岁（30~70岁）。按照Ann Arbor分期标准，ⅠEA期 14 例，ⅡEA 期8例，ⅢEA 期3例，ⅢEB 期1例，ⅣEA 期2例；其中B细胞来源25例，外周T细胞来源3例。治疗情况：单纯手术组2例，单纯化疗组2例，综合治疗组24例；化疗一般采用 CHOP 方案，4~8个周期。［结果］ 随访时间6~139个月，中位随访时间62.5个月，全组患者中位生存时间为66个月（95%CI：50~84），5年生存率为45.6%。［结论］ PBL病理以B细胞来源最常见。目前多选择化疗及放疗为基础结合手术的综合治疗，但仍有待多中心随机对照研究加以证实。 |
| 英文摘要: |
| Abstract:［Purpose］ To explore the clinicopathologic features and the treatment for primary breast lymphoma (PBL). ［Methods］ The clinical data of 28 cases with PBL were analyzed retrospectively. Of the 28 cases with PBL，median age at diagnosis was 46 years old. According to the Ann Arbor staging standard，14 cases were stageⅠEA; 8，ⅡE; 3，ⅢEA; 1，ⅢEB ; and 2，ⅣEA. According to the WHO 2001 lymphoma classification system，25 cases were B-cell lymphoma. Two cases underwent surgery alone while 2 cases received chemotherapy alone，24 cases received combined treatment. The chemotherapy regimen used was CHOP for an average of 4~8 cycles. ［Results］ The median follow-up peroid was 62.5 months (ranging from 6~139 months). The median survival was 66 months (95%CI: 50~84). The 5-year overall survival (OS) rate was 46.5%. ［Conclusions］ PBL’s main pathological subtype is large B-cell lymphoma. At present,chemotherapy or radiotherapy combined with surgery are the most common choice. A multi-center controlled randomized clinical trial should be pursued to confirm these observations． |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|